Latest GlaxoSmithKline Stories
DUBLIN, May 05, 2015 /PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/sdfqn9/human_vaccine)
LONDON and SAN FRANCISCO, April 30, 2015 /PRNewswire/ -- GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc.
A Zofran lawsuit news update is provided from attorneys at the Onder Law Firm handling a birth defects lawsuit against GlaxoSmithKline in Alabama. St.
San Diego personal injury lawyers of The Law Office of Melinda J. Helbock, A.P.C.
Nicorette mini Lozenge Returns to Most Store Shelves PARSIPPANY, N.J., April 27, 2015 /PRNewswire/ -- GlaxoSmithKline Consumer Healthcare (GSKCH) today announced 2 mg and 4 mg Nicorette(®)
Litigation Would Cite How Drug Can Cause Birth Defects When Used by Pregnant Women CHICAGO, April 24, 2015 /PRNewswire/ -- A Chicago law firm said today it is considering filing the
Attorneys representing clients nationwide in Zofran lawsuits provide an update and commentary on one of the Onder Law Firm’s pending Zofran lawsuits for birth defect allegations.
Litigation Would Cite How Drug May Cause Birth Defects When Used by Pregnant Women CHICAGO, April 22, 2015 /PRNewswire/ -- A Chicago law firm said today it is considering filing the
DALLAS, April 22, 2015 /PRNewswire/ -- RnRMarketResearch.com adds Herpes Zoster (Shingles) - Pipeline Review, H1 2015 market research report of 61 pages published in March
NEW YORK, April 21, 2015 /PRNewswire/ -- Zofran lawsuits (http://www.zofranlawsuit2015.com/
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.